Effect of rimonabant on weight reduction and cardiovascular risk.
Hirschel
Bernard
B
D000818:Animals; D001161:Arteriosclerosis / Q000139:chemically induced / Q000503:physiopathology; D063387:Cannabinoid Receptor Antagonists; D018450:Disease Progression; D006801:Humans; D051379:Mice; D009765:Obesity / Q000188:drug therapy*; D010880:Piperidines / Q000009:adverse effects* / Q000627:therapeutic use; D011720:Pyrazoles / Q000009:adverse effects* / Q000627:therapeutic use; D000077285:Rimonabant; D012449:Safety
D063387:Cannabinoid Receptor Antagonists; D010880:Piperidines; D011720:Pyrazoles; D000077285:Rimonabant